WEB EXCLUSIVES
Impact of a Program Encouraging the Use of Generic Antipsychotics
Eric D. A. Hermes, MD; Michael Sernyak, MD; and Robert Rosenheck, MD
Academic detailing coupled with a provider survey did not decrease the rate of new prescriptions for costly, on-patent second-generation antipsychotics in a VA hospital.
2012 Volume 18 Number 8
Preventable Hospitalizations and Medicare Managed Care: A Small Area Analysis
Jayasree Basu, PhD
Despite increased enrollment, the role of Medicare managed care in explaining declines in preventable hospitalization rates diminished over time.
2012 Volume 18 Number 8
Home Care Program for Patients at High Risk of Hospitalization
Stuart Levine, MD, MHA; Bernard A. Steinman, PhD; Karol Attaway, MHA; Tyler Jung, MD; and Susan Enguidanos, PhD
Randomized controlled trial of a home care program for managed care patients resulted in lower probability of hospital admission and greater patient satisfaction with care.
2012 Volume 18 Number 8
Questioning the Widely Publicized Savings Reported for North Carolina Medicaid
Al Lewis, JD
Savings claims for Community Care of North Carolina raise many questions, concerning both arithmetic/epidemiologic plausibility and omission of presumably authoritative but contradictory source materials/citations.
2012 Volume 18 Number 8
Measuring Migraine-Related Quality of Care Across 10 Health Plans
Valerie P. Pracilio, MPH; Stephen Silberstein, MD; Joseph Couto, PharmD, MBA; Jon Bumbaugh, MA; Mary Hopkins, RN; Daisy Ng-Mak, PhD; Cary Sennett, MD, PhD; and Neil I. Goldfarb, BA
Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
2012 Volume 18 Number 8
Addressing Gaps in Care: Impact of Barrier-Specific Medication Adherence Intervention
Richard A. Zabinski, PharmD, FAMCP; Elizabeth P. Skinner, PharmD; Erin K. Buysman, MS; and C. Ron Cantrell, PhD
An interactive voice response–administered “helpful hints” intervention compared with a letter-based intervention was associated with better adherence in patients with chronic diseases and suboptimal medication adherence at baseline.
2012 Volume 4 Number 4
Associating Medication Adherence With Improved Outcomes: A Systematic Literature Review
Kimberly A. Boswell, MD; Christopher L. Cook, PharmD, PhD; Steven P. Burch, RPh, PhD; Michael T. Eaddy, PharmD, PhD; and C. Ron Cantrell, PhD
This literature-based analysis supports association between medication adherence and better clinical, economic, and utilization outcomes in chronic disease populations, with variability across specific diseases.
2012 Volume 4 Number 4
Switching Between Different ARBs in Patients With Controlled BP
Khalid M. Kamal, PhD; Christopher Zacker, RPh, PhD; and Louis Civitarese, DO
Therapeutic switches in patients with controlled blood pressure are not uncommon and it is important to evaluate the clinical and economic impact of these switches on patient outcomes.
2012 Volume 4 Number 4
Impact of Medication Adherence on Work Productivity in Hypertension
Samuel Wagner, PhD, RPh; Helen Lau, MS; Feride Frech-Tamas, PhD, RPh; and Shaloo Gupta, MS
This cross-sectional study found that advanced stages of hypertensive disease and poor antihypertensive medication adherence were associated with work productivity impairment among employed persons.
2012 Volume 4 Number 4
Patient Safety–Focused Medication Therapy Management: Challenges Affecting Future Implementation
Rowena J. Dolor, MD, MHS; Andrew L. Masica, MD, MSCI; Daniel R. Touchette, PharmD, MA; Scott R. Smith, PhD; and Glen T. Schumock, PharmD, PhD, MBA
Lessons learned from implementation of a pharmacist-delivered medication therapy management intervention in primary care can inform future studies and be adopted into real-world clinical settings.
2012 Volume 18 Number 7